Instead of making identical copies of the weight loss drugs, Empower and other compounders combine a GLP-1, either semaglutide or tirzepatide, with vitamin B12, change the dosage strength, or offer different delivery methods
Samuel Cross of Imperial College London said that if generic production reduces prices to sustainable levels, millions more people could access treatment [Source: canadianaffairs.news/2026/03/08/anti-obesity-treatment-could-cost-as-little-as-3-per-month-study/]
it is not licensed by the MHRA for any clinical indication
Preliminary findings suggest that the majority experience their worst fatigue in the initial 4 to 8 weeks of treatment
Adequate hydration also helps prevent constipation, which can alternate with diarrhea in some patients
5316, The Drug Shortage Compounding Patient Access Act PSM sent a letter explaining how H.R